Results 201 to 206 of about 12,907 (206)

Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole

Bioorganic and Medicinal Chemistry Letters, 2005
Wallace T Ashton, Kathryn A Lyons, Huaibing He   +2 more
exaly  

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

Nutrition, Metabolism and Cardiovascular Diseases, 2016
Emanuel Raschi, Elisabetta Poluzzi, Giulio Marchesini   +2 more
exaly  

Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes

Expert Opinion on Drug Safety, 2015
André J Scheen
exaly  

Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients

American Journal of Medicine, 2017
Chun-Chin Chang, Yung-Tai Chen, Chien-Yi Hsu   +2 more
exaly  

Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: Close analogs of JANUVIA™ (sitagliptin phosphate)

Bioorganic and Medicinal Chemistry Letters, 2007
Dooseop Kim, Scott D Edmondson, Anthony Mastracchio   +2 more
exaly  

Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors

2012
openaire   +1 more source